 | Up a level |
Collaboration networkThis graph maps the connections between all the collaborators of {}'s publications listed on this page.
Each link represents a collaboration on the same publication. The thickness of the link represents the number of collaborations.
Use the mouse wheel or scroll gestures to zoom into the graph.
You can click on the nodes and links to highlight them and move the nodes by dragging them.
Hold down the "Ctrl" key or the "⌘" key while clicking on the nodes to open the list of this person's publications.
Word cloudA word cloud is a visual representation of the most frequently used words in a text or a set of texts. The words appear in different sizes, with the size of each word being proportional to its frequency of occurrence in the text. The more frequently a word is used, the larger it appears in the word cloud. This technique allows for a quick visualization of the most important themes and concepts in a text.
In the context of this page, the word cloud was generated from the publications of the author {}. The words in this cloud come from the titles, abstracts, and keywords of the author's articles and research papers. By analyzing this word cloud, you can get an overview of the most recurring and significant topics and research areas in the author's work.
The word cloud is a useful tool for identifying trends and main themes in a corpus of texts, thus facilitating the understanding and analysis of content in a visual and intuitive way.
Alameh, M.-G., Lavertu, M., Merzouki, A., Biniecki, K., & Buschmann, M. D. (2014, May). Chitosan/siRNA nanoparticles demonstrate superior silencing efficiency and lower toxicity compared to lipid nanoparticles [Abstract]. 17th Annual Meeting of the American Society of Gene & Cell Therapy, Washington, DC. Published in Molecular Therapy, 22(S1). Available
Alameh, M., DeJesus, D., Benhamadi, M., Jean, M., Buschmann, M. D., & Merzouki, A. (2011, May). Chitosan nanoparticulate system for the delivery of siRNA targeting genome caretakers for the development of potential cancer therapies [Paper]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Unavailable
Alamech, M., Jean, M., DeJesus, D., Buschmann, M. D., & Merzouki, A. (2010). Chitosanase-based method for RNA isolation from cells transfected with chitosan/siRNA nanocomplexes for real-time RT-PCR in gene silencing. International Journal of Nanomedicine, 5, 473-481. Available
Buschmann, M. D., Merzouki, A., Lavertu, M., Thibault, M., Jean, M., & Darras, V. (2013). Chitosans for delivery of nucleic acids. Advanced Drug Delivery Reviews, 65(9), 1234-1270. External link
Buschmann, M. D., Thibault, M., Merzouki, A., Lavertu, M., Ma, P. L., Jean, M., Darras, V., & Winnik, F. M. (2010, May). Polynucleotide delivery with chitosans [Paper]. 93rd Canadian Chemistry Conference, Toronto, Ontario. Unavailable
Buschmann, M. D., Thibault, M., Merzouki, A., & Lavertu, M. (2009, August). Polynucleotide delivery with chitosans [Paper]. 8th World Congress of Chemical Engineering, Montréal, Québec. Unavailable
DeJesus, D., Alameh, M., Jean, M., Lascau, V., Buschmann, M. D., & Merzouki, A. (2011, May). Therapeutic lowering of circulating ApoB in atherosclerotic mice by intravenous administration of chitosan-siRNA nanoparticles [Paper]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Unavailable
Jean, M., Jeandupeux, D., Merzouki, A., & Buschmann, M. D. (2014, May). Combining delivery of GLP-1 gene expressing plasmid and DPP-4 gene silencing siRNA using Chitosan-based nanoparticles for Type-2 Diabetes treatment [Abstract]. 17th Annual Meeting of the American Society of Gene & Cell Therapy, Washington, DC (1 page). Published in Molecular Therapy, 22(S1). Available
Jean, M., Derbali, R., DeJesus, D., Jeandupeux, D., Merzouki, A., & Buschmann, M. D. (2014, May). Apolipoprotein B knock-down by Chitosan/ApoB-siRNA nanoparticles lowers plasma cholesterol in atherosclerosis mouse model [Abstract]. 17th Annual Meeting of the American Society of Gene & Cell Therapy, Washington, DC (1 page). Published in Molecular Therapy, 22(S1). Available
Jean, M., Behhammadi, M., Sidique, A., Jeandupeux, D., Merzouki, A., & Buschmann, M. D. (2014, May). P-Glycoprotein knock-down by Chitosan/Mdr1-siRNA nanoparticles increases sensitivity to chemotherapeutics [Abstract]. 17th Annual Meeting of the American Society of Gene & Cell Therapy, Washington, DC (1 page). Published in Molecular Therapy, 22(S1). Available
Jean, M., Alameh, M., De Jesus, D., Thibault, M., Lavertu, M., Darras, V., Nelea, M., Buschmann, M. D., & Merzouki, A. (2012). Chitosan-Based Therapeutic Nanoparticles for Combination Gene Therapy and Gene Silencing of in Vitro Cell Lines Relevant to Type 2 Diabetes. European Journal of Pharmaceutical Sciences, 45(1-2), 138-149. External link
Jean, M., Alamech, M., Buschmann, M. D., & Merzouki, A. (2011). Effective and safe gene-based delivery of GLP using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of diabetes. Gene Therapy, 18(8), 807-816. External link
Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (2011, May). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Paper]. 14th Annual Meeting American Society of Gene and Cell Therapy, Seattle, WA, USA. Unavailable
Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (2011, May). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Paper]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec, Canada. Unavailable
Jean, M., Smaoui, F., Lavertu, M., Méthot, S., Bouhdoud, L., Buschmann, M. D., & Merzouki, A. (2009). Chitosan-Plasmid Nanoparticle Formulations for Im and Sc Delivery of Recombinant Fgf-2 and Pdgf-Bb or Generation of Antibodies. Gene Therapy, 16(9), 1097-1110. External link
Liberelle, B., Merzouki, A., & De Crescenzo, G. (2013). Immobilized Carboxymethylated Dextran Coatings for Enhanced ELISA. Journal of Immunological Methods, 389(1-2), 38-44. External link
Liberelle, B., Bartholin, L., Boucher, C., Murschel, F., Jolicoeur, M., Durocher, Y., Merzouki, A., & De Crescenzo, G. (2010). New Elisa Approach Based on Coiled-Coil Interactions. Journal of Immunological Methods, 362(1-2), 161-167. External link
Merzouki, A., & Buschmann, M. D. (2017). Compositions and methods for efficacious and safe delivery of siRNA using specific chitosan-based nanocomplexes. (Patent no. US9809821). External link
Merzouki, A., & Buschmann, M. D. (2013). Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1. (Patent Application no. US20130210717). External link
Merzouki, A., Buschmann, M. D., Jean, M., Young, R. S., Liao, S., Gal, S., Li, Z., & Slilaty, S. N. (2012). Adva-27a, a Novel Podophyllotoxin Derivative Found to Be Effective Against Multidrug Resistant Human Cancer Cells. Anticancer Research, 32(10), 4423-4432. External link
Merzouki, A., Alameh, M., DeJesus, D., Jean, M., Darras, V., Thibault, M., Lavertu, M., & Buschmann, M. D. (2012). Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery. International Journal of Nanomedicine, 7, 1399-1414. Available
Méthot, S., Lavertu, M., Sun, J., Smaoui, F., Jean, M., Merzouki, A., & Buschmann, M. D. (2007, September). Efficient in vivo gene delivery using chitosan/DNA nanoparticles for applications in cartilage repair [Paper]. 7th World Congress International Society for Cartilage Repair, Warsaw, Poland. External link
Sabbahi, R., Lavallée, R., Merzouki, A., & Guertin, C. (2010). Differentiation of entomopathogenic fungus Beauveria bassiana (Ascomycetes: Hypocreales) isolates by PCR-RFLP. [Différentiation d’isolats du champignon entomopathogène Beauveria bassiana (Ascomycetes : Hypocreales) par PCR-RFLP]. Phytoprotection, 90(2), 49-56. External link
Smaoui, F., Buschmann, M. D., Jean, M., Bouhdoud, L., Henrichon, M., Méthot, S., & Merzouki, A. (2006, June). The chitosan used as a delivery system of therapeutic growth factors for the induction of cartilage regeneration [Paper]. Canadian Society of Microbiologists Annual Conference, London, Ontario. Unavailable
Thibault, M., Astolfi, M., Tran-Khanh, N., Lavertu, M., Darras, V., Merzouki, A., & Buschmann, M. D. (2011, May). Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexes [Paper]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Unavailable
Thibault, M., Astolfi, M., Tran-Khanh, N., Lavertu, M., Darras, V., Merzouki, A., & Buschmann, M. D. (2011). Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexes. Biomaterials, 32(20), 4639-4646. External link
